Mednet Logo
HomeEndocrinologyQuestion

What patient-specific factors would influence your decision to initiate semaglutide therapy in patients with HIV-associated lipohypertrophy?

1
1 Answers
Mednet Member
Mednet Member
Infectious Disease · UT Southwestern

I would consider it if the patient had diabetes. But there is not much data on this question.

Register or Sign In to see full answer

What patient-specific factors would influence your decision to initiate semaglutide therapy in patients with HIV-associated lipohypertrophy? | Mednet